Objective and design The renal expression of H 1 and H 2 receptors has previously been demonstrated, while that of the H 4 receptor has been poorly investigated, and thus the aim of this research was to investigate the expression of the H 4 receptor in the kidney of diabetic rats. Material or subjects 24 8-week-old male Wistar rats. Treatment Diabetes was induced in 12 rats by a single intravenous injection of streptozotocin, and animals were killed 6 weeks later.
Introduction
Histamine is a biogenic amine that exerts many (patho) physiological effects through its interaction with four subtypes of G-protein-coupled receptors, designated H [1] [2] [3] [4] , which are differentially expressed in various tissues and cell types. It is synthesized from L-histidine through the catalytic activity of the rate-limiting enzyme histidine decarboxylase (HDC). Although HDC is principally expressed in mast cells, the most important source of histamine, it is well recognized that a number of other cell types, such as tuberomammillary nucleus (TMN) neurons in the brain and parietal cells in the stomach [1] , also express this enzyme. Notably, HDC expression has been also reported in the kidney, where it was found in the proximal tubule [2] , thus in keeping with the demonstrated ability of the kidney to produce histamine.
In particular, in humans the renal histamine content markedly exceeds plasma levels (\10 -8 M in plasma vs.
&10
-6 M in glomeruli) [3] . Indirect demonstrations sustain the hypothesis that histamine could be involved in renal pathophysiology in humans. In fact, it was demonstrated in healthy subjects that loading doses of L-histidine led to an increase in histamine concentration in urine, but not in blood [4] , and that urinary and blood levels of histamine are elevated following renal transplantation [5] .
Some studies suggest that histamine may be involved in diabetes-related kidney disease. Studies performed in streptozotocin (STZ) diabetic rats have shown, consistently with a generalized effect of diabetes on inducing an increase in histamine, a greater content of histamine in the kidney of diabetic animals than that of controls [6, 7] . This increase has been related to a significantly greater tissue HDC activity of diabetic rats than controls without a concomitant decrease in histaminase activity [8] , an enzyme that catalyzes the inactivation of histamine. Besides, it has been suggested that renal histamine may represent one triggering stimulus for the functional microangiopathy in diabetes mellitus, which may lead to the development of diabetic nephropathy. In fact, it has been reported, in rats, that histamine reduces the ultrafiltration coefficient [9] . These data are in keeping with more recent studies aimed at assessing the role of mast cells in the kidney. It is well recognized that, in the normal kidney, mast cells are constitutively present in low numbers. However, their density and activation increase in the renal cortical tubulointerstitium and in the periglomerular and perivascular area, but not in glomeruli, in a variety of human renal diseases, including diabetic nephropathy [10] [11] [12] .
Hitherto, the renal effects of histamine have been related to the activation of H 1 and H 2 receptors, both identified in the glomeruli [3, 13] , while H 4 receptor expression in the kidney has been poorly investigated. A very low level of H 4 receptor mRNA has been reported in the kidney of dog, monkey, rat, mouse, guinea pig and pig [14] [15] [16] [17] [18] . Despite the demonstration of an increasing histamine release in the diabetic kidney, there is no evidence for the involvement of H 4 receptor expression in diabetes-related kidney disease. Thus, in order to gain further insight into the histamine signal in the diabetic kidney, the aim of this pilot study was to investigate the expression of H 4 receptors in the kidney of diabetic rats with severe hyperglycemia.
Materials and methods

Animals and protocols
Male 8-week-old Wistar rats (Harlan-Italy, Udine, Italy) were provided with a Piccioni pellet diet (No. 48; Gessate Milanese, Italy) and water ad libitum. Animal care was in compliance with Italian regulations on the protection of animals used for experimental and other scientific purposes (D.M. 116/92). The experimental protocol was approved by the Turin University Ethics Committee for the animal use.
Diabetes induction
Insulinopenic diabetes was induced by a single intravenous tail vein injection of streptozotocin (STZ; 50 mg/kg) diluted in citrate buffer 0.1 M (pH 4.0) in accordance with the literature (Wu and Huan, 2008). Rats were randomized into two groups: (1) non-diabetic animals (n = 12) and (2) diabetic animals (n = 12). A blood sample was collected 4 days after the STZ injection, and plasma glucose was determined using a glucose analyzer (Accu-Chek Compact System; Roche Diagnostics, Basel, Switzerland). Diabetes was defined by a blood glucose level of[300 mg/ dl. Six weeks after induction of diabetes, when the experimental rats reached a blood glucose level [300 mg/dl (severe hyperglycemia), they were weighed and placed in metabolism cages to collect 24 h urine. Animals were killed after aortic exsanguination under anaesthesia by intraperitoneal injection (30 mg/kg) of Zoletil 100 (15 mg/ kg tiletamine ? 15 mg/kg zolazepam; 100 mg/ml; Laboratoires Virbac, France). Blood samples were stored at -80°C. Kidneys were isolated, weighed and processed for biochemical or histological evaluation according to standard procedures by rapidly freeze-clamping with liquid nitrogen and stored at -80°C or fixing in 4 % paraformaldehyde solution overnight, respectively.
Measurement of biochemical and histological parameters
Serum and urine creatinine concentrations were measured spectrophotometrically at 490 nm by the Jaffé kinetic reaction (Schlatzer et al. 2009), using commercially available kits (Cat. Nos. KB02-H1, K002-H1; DetectX, Arbor Assays, MI, USA). Renal creatinine clearance was calculated by the standard formula C = (U 9 V)/P, where U is the concentration in urine, V is urine flow rate, and P is the plasma concentration. Creatinine concentrations and creatinine clearance were used as indicators of impaired renal function, while N-acetyl-b-glucosaminidase (NAG), measured in the urine by a colorimetric assay (Roche Diagnostics), was used as a marker of tubular injury [19] .
Histological sections, 5 lm thick, were cut from the paraffin-embedded kidney samples. Tissue sections were stained with periodic acid-Schiff (PAS) in a single session to minimize artifactual differences in the staining. Photomicrographs of the histological slides were randomly taken with a digital camera connected to a light microscope equipped with a 409 objective. In total, 10 images and 60 glomeruli from each rat were examined by two independent investigators blinded to the experimental group.
RT-PCR and quantitative real-time PCR analysis
The analyses were performed as previously described [20] . Briefly, RT-PCR amplifications were performed in 25 ll reaction mixtures containing 1.0 ll of cDNA, 2.5 ll of 109 buffer, 1.0 ll of 50 mM MgCl 2 , 0.20 ll of 25 mM dNTPs mix, 0.05 U of EuroTaq DNA polymerase (Euroclone, Milan, Italy), and 2.5 nM of sequence-specific oligonucleotide primers (Sigma-Genosys, Milan Italy):
. PCR amplicons were resolved in an ethidium bromide-stained agarose gel (3 %) by electrophoresis, and signals were quantified using NIH ImageJ 1.41 software. 18S gene expression was used as an internal control. Real-time PCR experiments were performed in 25 ll reaction mixtures containing 10 ng of cDNA template. Power SYBR Ò Green PCR Master Mix and AmpliTaq Gold Ò DNA Polymerase LD (Applied Biosystems, Inc., Foster City, CA, USA) was directed to detect and quantify H 4 receptor mRNA. Relative quantification of the products was performed using a 48-well StepOne TM Real Time System (Applied Biosystems). For all real-time PCR analyses, 18S mRNA was used to normalize RNA inputs. Antibodies H 4 receptor was detected by using the anti-hH 4 receptor (374-390) antibodies produced and validated for detecting both human and rodent H 4 receptors in the School of Biological and Biomedical Sciences, Durham University [21] [22] [23] [24] [25] [26] [27] . Briefly, the antibody was generated against the last 17 amino acids of the C-terminal tail of the H 4 receptor conjugating the peptide corresponding to the amino acids CIKKQPLPSQHSRSVSS to thyroglobulin by the cysteinecoupling method [28] . The resultant conjugate was used to generate polyclonal antibodies in rabbits as previously described [29] . The selectivity of the anti-hH 4 receptor antibody was confirmed by blockade with the C-terminal peptide of the H 4 receptor and a lack of cross-reactivity with the human H 3 receptor, the most closely related G-coupled receptor [26] .
For comparison, a commercial available anti-H 4 receptor (Y-19; sc-33967 Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA) was also employed. The antibodies for renal markers, aquaporin (AQP)1, AQP2, Na-K-Cl cotransporter (NKCC)1, tissue non-specific alkaline phosphatise (TNAP) and Tamm-Horsfall glycoprotein (THP), were purchased from Santa Cruz Biotechnology, Inc., while the secondary biotinylated anti-rabbit and anti-goat antibodies were from Vector Laboratories, Inc. (Burlingame, CA, USA) and the secondary Alexa Fluor-488 anti-goat or Alexa Fluor-594 anti-rabbit polyclonal antibodies were from Molecular Probes (Leiden, The Netherlands).
Immunohistochemistry
Conventional immunohistochemical procedures were employed as described previously [30, 31] . Briefly, immunoperoxidase staining for H 4 receptor, AQP1, AQP2, NKCC1, TNAP and THP was performed on 5 lm sections for formalin-fixed tissue using an appropriate antigen retrieval (sodium citrate 50 mM pH 8.4 for 30 min at room temperature followed by sodium citrate 50 mM pH 8.4 for 30 min at 80°C for the anti-hH 4 receptor (374-390); or sodium citrate 10 mM pH 6.9 for 3 cycles of 20 s in microwave 750 W for the anti-H 4 receptor (Y-19)); sections were incubated overnight with anti-hH 4 receptor (374-390) or anti-H 4 receptor (Y-19) (2 lg/ml) or anti-AQP1, -AQP2, -AQP3, -NKCC1, -TNAP and -THP (4 lg/ml) at 4°C, followed by a three-layer streptavidin-biotin-peroxidase complex staining method (Vectastain ABC Elite kit and 3 0 ,3-diaminobenzadine tetrahydrochloride, DAB; Vector Laboratories, Inc.). Tissue was also screened in the absence of primary antibody. In all cases, a major part of the staining elicited by the untreated antibody was abolished. All sections were stained or immunostained in a single session to minimize artifactual differences in the staining. Photomicrographs of the histological slides were randomly taken with a digital camera connected to a light microscope equipped with a 409 objective (Leica DM750).
Immunofluorescence and confocal analysis After antigen retrieval and blocking, 5 lm kidney paraffin sections were incubated with primary anti-H 4 receptor and anti-THP or anti-AQP1 antibodies, followed by incubation with Alexa Fluor-488 anti-goat or Alexa Fluor-594 antirabbit polyclonal antibodies. After counterstaining with DAPI, photomicrographs were obtained by a confocal laser-scanning microscope LSM-510 microscope equipped with a 409 objective (Carl Zeiss, Oberkochen, Germany).
Image analysis
Images were processed by ImageJ 1.41 (NIH, USA) software and quantified using the Color Deconvolution image analysis tool as previously described [30] [31] [32] [33] . Briefly, H 4 staining defined by diaminobenzidine was colour deconvoluted from counter-stained sections. A threshold was chosen for identifying H 4 -positive staining areas and used on all slides in the study without modification. The percentage area was calculated for H 4 -positive tissue. Values are mean ± SEM of the optical density (in arbitrary units) measurements of individual rats (ten images/zone each) from the different experimental groups.
Data analysis
Results are shown as mean ± SEM and were analysed by Student's t test or one-way ANOVA with Dunnett's multiple comparison, and Student-Newman-Keuls tests were used to determine significant differences between means: p-values less than 0.05 were considered significant. Data analysis assumed normality, using Prism 4 software from Graphpad (CA, USA).
Results
Pathophysiology and renal histology
As shown in Table 1 , in comparison to controls, body weight was reduced and blood glucose level was increased in diabetic rats. The kidney-to-body-weight ratio was significantly higher, suggesting an organ hypertrophy. The creatinine clearance was significantly decreased. The increase in urinary NAG level suggested tubular dysfunction (Table 1) . Consistently, these biochemical abnormalities were associated with clear changes in renal histology. Using PAS staining, histological analysis of kidney sections from the diabetic animals showed severe tubular alterations and moderate glomerular modifications. In fact, in comparison to controls, STZ-treated rats revealed interstitial space increase and marked tubular degeneration associated with robust tubular epithelial cells loss and decreased PAS positivity of the brush-border membranes (Fig. 1a, b) . Moreover, the glomeruli of diabetic rats displayed moderate capsular fibrosis and tuft-to-capsule adhesion, with capillary dilation and mild mesangial matrix expansion (Fig. 1c, d ).
Renal H 4 receptor expression in diabetic rats
In control rats the H 4 receptor gene was constitutively expressed, although unevenly and at a very low level (Fig. 2a) . In contrast, a higher expression level was detected in STZ-treated animals (Fig. 2b) . The PCR data were confirmed by immunohistochemical analysis (Fig. 3) . In particular, while there was very weak H 4 receptor-like immunoreactivity in control rats, a high level of labelled cells in both medulla and cortex of diabetic animals was observed. In contrast, in the papilla the immunoreactivity was generally very low. Interestingly, H 4 receptor-like immunoreactivity was not detectable in the glomeruli. This observation was confirmed using a quantitative image analysis, performed with the Color Deconvolution image analysis tool. As shown in Fig. 4 , the calculated percent area for the H 4 receptor-like immunoreactivity was significantly higher in the medulla, while the papilla showed modest DAB positivity. These results were obtained by using the anti-hH 4 receptor (374-390) antibody. Comparable results were observed with the commercially available anti-H 4 receptor (Y-19). The similar results validate the use of the anti-hH 4 receptor (374-390) antibody to detect the H 4 receptor in the rat kidney.
H 4 receptor cellular localization
The above data, indicating a higher H 4 receptor-like immunoreactivity in the medulla, suggest a tubular expression of the receptor. Thus, we performed sequential section staining with different tubular cell markers to distinguish between the different portions of the nephron. When H 4 receptor immunostaining was compared to individual tubular cell markers, a close overlap in expression topology was suggested with the markers of the loop of Henlé (Online Resource 1). To confirm and refine this result, immunoflorescence staining and confocal analysis was performed with both THP, a marker of the thick ascending limb of the loop of Henlé, and AQP1, a marker of both the proximal tubules, the thin descending limb of the loop of Henlé, and also expressed on some walls of microvessels. As shown in Fig. 5 , H 4 receptor colocalizes with both THP and AQP1 proteins, and it is mainly expressed at the apical membrane of the epithelial cells. These results suggest that the H 4 receptor is mainly expressed by resident renal cells of the loop of Henlé.
Discussion
Our results demonstrate for the first time that the H 4 histamine receptor is mainly expressed by cells of the loop of Henlé, and that this protein is significantly upregulated in the kidneys of diabetic animals, hence suggesting a possible role of the H 4 receptor in the pathogenesis of diabetes-associated renal disease.
Herein, we have reported the immunohistochemical identification of the H 4 receptor in the kidney. The first observation of renal H 4 receptor expression dates back to its discovery in 2000 [18, [34] [35] [36] [37] [38] [39] . In particular, RT-PCR experiments demonstrated the renal expression of the gene encoding for the H 4 receptor [36] . These data were not confirmed by Northern blot analysis, so it has been postulated that the H 4 receptor could be expressed by a minor cell population. Later, the constitutive but very low H 4 receptor gene expression was confirmed in different species [14] [15] [16] [17] [18] 36] ; however, none of these studies provided for the topological evaluation and cell type identification of the receptor. In contrast, our work was directed towards assessing the intra-renal distribution and levels of H 4 receptor. Consistently with previous studies, we measured, in control rats, H 4 receptor mRNA at the lower limit of detectability. This very low expression is in keeping with the weak positivity when immunohistochemistry evaluation was performed. Importantly, we observed that all diabetic animals with overt hyperglycemia (6 weeks after induction of diabetes), although not meeting the criteria for diabetic nephropathy, showed renal damage and expressed profoundly higher levels of H 4 receptor, thus suggesting a strong association between diabetes-associated renal damage and H 4 receptor overexpression. However, the present pilot study was only observational, and future work will focus on the functional consequences of the elevated levels of H 4 receptor and the respective regulatory mechanisms.
Previously, it has been shown that diabetic animals have a higher intra-renal histaminergic level [6, 7] . Moreover, parallel to the enhanced HDC enzyme activity [8] , an increase in number and degranulation of mast cells was also demonstrated in the diabetic kidney [10] [11] [12] . The resulting higher histamine renal content was previously linked to the microvascular diabetes-associated changes in the glomerulus, where the expression of only H 1 and H 2 receptors was demonstrated [3, 13, 40] . However, all these studies were initiated prior to the discovery of the H 3 and H 4 receptors and were based on pharmacological characterization performed using dimaprit. This compound was initially characterized as a selective H 2 receptor agonist, but nowadays it has been found to act also on the H 4 receptor subtype, but with a much higher affinity [41] . Thus, these data suggest that a possible role of the H 4 receptor in mediating the renal effect of histamine could not be ruled out. Moreover, the discovery of H 1 and H 2 receptors only in the glomerulus led researchers to discard the hypothesis of a potential role for histamine in the tubules. Our findings, which demonstrate that the H 4 receptor subtype is absent in the glomeruli, but present in the tubules, leads us to revisit a tubular effect for histamine. This idea is in keeping with the presence of mast cells, not only in the periglomerular and perivascular areas, but also in the tubulointerstitium and, occasionally, in the wall of atrophied tubules [12] . Thus, a possible role of histamine released by mast cells and of the H 4 receptor in the tubular interstitium in promoting renal inflammation and fibrosis [11, 12] would be an intriguing hypothesis. Notably, the H 4 receptor is exquisitely sensitive to local histamine levels [42] .
Another original contribution of our study is to provide an intra-nephron localization of the H 4 receptor. [43] , leading us to hypothesize an active role of this receptor in modulating the loop of Henlé function(s), such as the transmembrane soluble transport processes. This study adds to the growing list of cell types expressing the H 4 receptor, subserving putative distinct roles to the other histamine receptors in the body, the latter including exocrine and endocrine functions in salivary glands [44] and the gastrointestinal tract [25] , respectively.
Collectively, these data provide compelling evidence for kidney H 4 expression and an anatomical basis which strongly suggests that the H 4 receptor could play a role in the onset/progression of diabetes-associated renal disease. Interestingly, although expression differences were observed among species [14, 15, 17, 18, 34] , the similar tissue distribution in different mammals indicates conserved and comparable physiological roles of the H 4 receptor across species. Therefore, we could speculate on similar roles in humans. On this basis, it is possible to hypothesize that our data on diabetic rats could have a positive translation to diabetic patients. However, whether this receptor has a compensatory or pathological implication remains to be established. In particular, understanding which effects an activation of H 4 receptor could exert on the loop of Henlé function is still to be resolved, and could represent the basis for proposing the renal H 4 receptor as a new potential pharmacological target for treating diabetesassociated renal disease.
